Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIA Randomised, Double-blind, Double Dummy, Placebo and Active Controlled 5-Way Cross-over Trial to Examine the Bronchodilator Effects of PF-610,355 and to Test for Superiority Versus Placebo in Reversible Asthmatic Patients

NCT00468975 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00468975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00468975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIA Randomised, Double-blind, Double Dummy, Placebo and Active Controlled 5-Way Cross-over Trial to Examine the Bronchodilator Effects of PF-610,355 and to Test for Superiority Versus Placebo in Reversible Asthmatic Patients
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
Not reported
Enrollment
42
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

asthma